Incuvate Sues Penumbra Over Alleged Patent Infringement of Thrombectomy Technology
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
Philips will collaborate with Johns Hopkins University and Boston University to develop technologies for remote and increasingly automated endovascular procedures.
Penumbra says THUNDERBOLT is currently the only computer-assisted vacuum thrombectomy (CAVT) device available in the US for stroke treatment.